Profil bibliographique

Jordi Craven–Bartle

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

80Publications signalées

462Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Glioma Diagnosis and TreatmentFerroptosis and cancer prognosisProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Publications récentes

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data files S1 a_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table S3 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table S1 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig. S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig. S3 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Table S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig S1 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig. S4 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data files S1 a_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Table S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.